The SH3b cell wall–binding domain of SpM23_B peptidoglycan hydrolase has antimicrobial activity

Bacterial peptidoglycan hydrolases (PGHs) are enzymes that degrade the peptidoglycan layer of bacterial cell walls and are essential for cell wall remodeling during growth, division, and cell wall turnover. PGHs commonly comprise an enzymatically active domain (EAD) and a cell wall–binding domain (CBD). Src Homology 3b (SH3b) domains are widely recognized as bacterial surface-targeting modules that enhance the activity and specificity of PGHs. However, their potential antimicrobial functions independent of the catalytic domain remain largely unexplored. Here, we investigated the antimicrobial properties of CBD_Sp_B, an SH3b domain derived from the SpM23_B PGH of Staphylococcus pettenkoferi . CBD_Sp_B exhibited potent bactericidal activity against all tested bacterial strains and, unexpectedly, also showed antifungal activity against multiple Candida species, including the WHO critical-priority pathogen Candida auris . Electron microscopy revealed pronounced ultrastructural alterations in both bacterial and fungal cells following treatment. SYTOX Green assays showed no significant membrane permeabilization, whereas DiSC 3 (5) measurements demonstrated a loss of bacterial membrane potential, indicating membrane depolarization as a component of its antimicrobial activity. Further analysis identified the C-terminal region of CBD_Sp_B as a key determinant of its antimicrobial function. However, its activity was strongly dependent on ionic strength and was abolished at NaCl concentrations ≥ 25 mM, limiting applications under physiological conditions. Our findings reveal a previously unrecognized antimicrobial function of an SH3b domain, extending its biological role beyond bacterial cell-wall binding. The broad-spectrum bactericidal and antifungal activity of CBD_Sp_B highlights its potential as a novel antimicrobial scaffold, particularly for topical and non-clinical applications under low-ionic-strength conditions, while also providing a basis for engineering salt-tolerant derivatives.

Authors

Institutions

Publication Details

Journal
BMC Biology
Published
2026-10-29
DOI
https://doi.org/10.1186/s12915-026-02773-7
Primary Topic
Bacterial Genetics and Biotechnology
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The SH3b cell wall–binding domain of SpM23_B peptidoglycan hydrolase has antimicrobial activity

Izabela Sabała, Magdalena Kaus‐Drobek, Paweł Mitkowski, Magdalena Gewartowska et al.
1 links
BMC Biology
Bacterial Genetics and Biotechnology
article

The SH3b cell wall–binding domain of SpM23_B peptidoglycan hydrolase has antimicrobial activity

Izabela Sabała, Magdalena Kaus‐Drobek, Paweł Mitkowski, Magdalena Gewartowska, Monika Janeczko, Joanna Stefańska, Marzena Nowacka, Małgorzata Korzeniowska née Wiweger
article en

Abstract

Bacterial peptidoglycan hydrolases (PGHs) are enzymes that degrade the peptidoglycan layer of bacterial cell walls and are essential for cell wall remodeling during growth, division, and cell wall turnover. PGHs commonly comprise an enzymatically active domain (EAD) and a cell wall–binding domain (CBD). Src Homology 3b (SH3b) domains are widely recognized as bacterial surface-targeting modules that enhance the activity and specificity of PGHs. However, their potential antimicrobial functions independent of the catalytic domain remain largely unexplored. Here, we investigated the antimicrobial properties of CBD_Sp_B, an SH3b domain derived from the SpM23_B PGH of Staphylococcus pettenkoferi . CBD_Sp_B exhibited potent bactericidal activity against all tested bacterial strains and, unexpectedly, also showed antifungal activity against multiple Candida species, including the WHO critical-priority pathogen Candida auris . Electron microscopy revealed pronounced ultrastructural alterations in both bacterial and fungal cells following treatment. SYTOX Green assays showed no significant membrane permeabilization, whereas DiSC 3 (5) measurements demonstrated a loss of bacterial membrane potential, indicating membrane depolarization as a component of its antimicrobial activity. Further analysis identified the C-terminal region of CBD_Sp_B as a key determinant of its antimicrobial function. However, its activity was strongly dependent on ionic strength and was abolished at NaCl concentrations ≥ 25 mM, limiting applications under physiological conditions. Our findings reveal a previously unrecognized antimicrobial function of an SH3b domain, extending its biological role beyond bacterial cell-wall binding. The broad-spectrum bactericidal and antifungal activity of CBD_Sp_B highlights its potential as a novel antimicrobial scaffold, particularly for topical and non-clinical applications under low-ionic-strength conditions, while also providing a basis for engineering salt-tolerant derivatives.

BMC Biology
John Paul II Catholic University of Lublin (PL), Medical University of Warsaw (PL), Mossakowski Medical Research Institute, Polish Academy of Sciences (PL), Polish Academy of Sciences (PL)
Narodowe Centrum Badań i Rozwoju
Good health and well-being
Openalex Percentile: Top 15%
Bacterial Genetics and Biotechnology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon